Table 4.
Other questionnaires
Parameter | Months | |||
---|---|---|---|---|
T0 | T3 | T6 | T12 | |
POMS Tension-Anxiety | 60.14 ± 6.14 | 65.71 ± 5.42 | 53.14 ± 4.86 | 58.71 ± 4.32 |
POMS Depression-Dejection | 63.42 ± 7.16 | 70.28 ± 6.75 | 58.14 ± 6.69 | 65.00 ± 6.88 |
POMS Anger-Hostility | 66.00 ± 7.45 | 68.14 ± 7.35 | 60.14 ± 4.36 | 61.85 ± 4.83 |
POMS Vigor-Activity | 44.14 ± 3.90 | 37.28 ± 3.34 | 44.00 ± 3.50 | 42.28 ± 5.42 |
POMS Fatigue-Inertia | 66.85 ± 7.25 | 72.00 ± 6.20 | 64.14 ± 6.42 | 64.56 ± 6.11 |
POMS Confusion-Bewilderment | 60.85 ± 7.64 | 68.28 ± 7.66 | 58.28 ± 5.81 | 61.14 ± 7.22 |
SF-36 Mental Index | 39.42 ± 5.98 | 35.00 ± 3.65 | 45.57 ± 4.33 | 48.42 ± 3.73* |
CES-D | 21.14 ± 6.55 | 27.85 ± 5.09 | 25.14 ± 4.71 | 22.71 ± 5.25 |
Scores of POMS, SF-36 and CESD questionnaires administered before (T0) and after 3 (T3), 6 (T6) and 12 (T12) months of testosterone replacement therapy. Values are mean ± SEM (n = 9). Wilcoxon test: * p < 0.04 vs T0